CDMO is Approved, Now What?

Watch an extended viewing of the MD&M BIOMEDigital forum discussing the trends in CDMO (Contract Device and Manufacturing Organization), compliments of Qosina. This panel of medtech experts discuss how the pandemic recovery is driving increased M&A, how long it will last, and what it means for employees, supply chain partners and customers. Hear how medical device companies identify which CDMOs are best positioned to be successful in a merger or acquisition situation, including insights gained from how they manage customers through the process, and why technology should be a core consideration when choosing a CDMO partner. Speakers: David Dykeman, Co-Chair Life Sciences & Medical Technology Group, Greenberg Traurig, LLP Carlo Stimamiglio, Partner, Alira Health Vincent Wong, Chief Quality Officer, Tomz Corporation Chuck Serrin, Vice President Industry Marketing, Propel